A clinical trial of SW-3431
Latest Information Update: 27 Jan 2025
Price :
$35 *
At a glance
- Drugs SW 3431 (Primary)
- Indications Uterine cancer
- Focus Adverse reactions
- 27 Jan 2025 New trial record
- 13 Jan 2025 According to a SpringWorks Therapeutocs media release, company plans to file an IND application for Uterine cancer by the end of 2025.